All In Biotech

Drug Trial Radar · NCT07594236

Phase 1 Study of C.001 in Retinal Degeneration

A Phase I Single-Center Open-label Study of C.001 in Patients With Significant Retinal Pigment Epithelium Mediated Maculopathy (RMM)

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Apr 7, 2026

Primary completion

Dec 31, 2028

Study completion Dec 31, 2029

Sponsor

Lead sponsor
Cellio Therapeutics IncIndustry
Sponsor type
Industry
Collaborators
California Institute for Regenerative Medicine (CIRM)
First posted
May 18, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a first-in-human Phase 1 study evaluating the safety and tolerability of C.001 in patients with retinal diseases involving degeneration of the retinal pigment epithelium. Participants will receive a single administration of C.001 delivered by subretinal injection. The study will evaluate three dose levels in a sequential manner. The primary objective is to assess the safety of C.001 over a 3-month period following administration. Participants will be followed for up to 12 months to further evaluate safety and explore changes in visual function and retinal structure.

Conditions

  • Geographic Atrophy
  • Stargardt Disease
  • RPE-mediated Maculopathy
  • Age Related Macular Degeneration

Interventions

  • InjectionBiological

    C.001 administered once via subretinal injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Ocular and Systemic Adverse EventsTime frame: 3 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Retina Vision Consultants

    Beverly Hills, California · Recruiting

  • Palo Alto Medical Foundation

    Palo Alto, California · Not yet recruiting

  • Retinal Consultants Medical Group

    Sacramento, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.